Xtandi Uni Eropa - Norwegia - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Ciprofloxacin Navamedic 2 mg/ ml Norwegia - Norwegia - Statens legemiddelverk

ciprofloxacin navamedic 2 mg/ ml

navamedic asa - ciprofloksacinlaktat - infusjonsvæske, oppløsning - 2 mg/ ml

Ciproxin 250 mg Norwegia - Norwegia - Statens legemiddelverk

ciproxin 250 mg

bayer ab - solna - ciprofloksacinhydroklorid - tablett, filmdrasjert - 250 mg

Dropizol 10 mg/ ml Norwegia - Norwegia - Statens legemiddelverk

dropizol 10 mg/ ml

pharmanovia a/s - morfin som opiumtinktur, standardisert - dråper, oppløsning - 10 mg/ ml

Rimactazid 150 mg / 75 mg Norwegia - Norwegia - Statens legemiddelverk

rimactazid 150 mg / 75 mg

sandoz - københavn - rifampicin / isoniazid - tablett, filmdrasjert - 150 mg / 75 mg

Rimstar Norwegia - Norwegia - Statens legemiddelverk

rimstar

sandoz - københavn - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg

Slenyto Uni Eropa - Norwegia - EMA (European Medicines Agency)

slenyto

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psykoleptiske - slenyto er angitt for behandling av søvnløshet hos barn og ungdom i alderen 2-18 med autism spectrum disorder (asd) og / eller smith-magenis syndrom, der sove hygieniske tiltak har vært utilstrekkelig.

Mecastrin 2 mg Norwegia - Norwegia - Statens legemiddelverk

mecastrin 2 mg

orifarm generics a/s - melatonin - depottablett - 2 mg

Melatonin Orifarm 3 mg Norwegia - Norwegia - Statens legemiddelverk

melatonin orifarm 3 mg

orifarm generics a/s - melatonin - tablett, filmdrasjert - 3 mg

Xenleta Uni Eropa - Norwegia - EMA (European Medicines Agency)

xenleta

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler for systemisk bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.